Thrombosis
Conference Coverage
ESC: Too much TV boosts PE risk
Key clinical point: Tuning in to the television for an average of 5 hours or more per day is independently associated with a sharply increased...
Conference Coverage
ESC: Rivaroxaban safety highlighted in real-world setting
The factor Xa inhibitor rivaroxaban was associated with low rates of bleeding and stroke in two observational studies that included more than 45,...
Commentary
The pros and cons of novel anticoagulants
Conference Coverage
VIDEO: LAA ablation safely treats long-standing, persistent Afib
News
Warfarin as effective as LMWH to prevent recurrent VTEs in cancer patients
Key clinical point: In cancer patients, tinzaparin (Innohep) does not significantly reduce recurrent venous thromboembolisms, overall mortality,...
News
Esophagogastric cancer chemotherapy commonly causes VTE
News
NICE recommends rivaroxaban for acute coronary syndrome
Rivaroxaban is recommended in combination with aspirin plus clopidogrel or aspirin alone for prevention of atherothrombotic events in people who...
News
Warfarin therapy highly unpredictable in real-world practice
News
Anticoagulant therapy not contraindicated in brain metastases
Treatment of venous thromboembolism with anticoagulation does not increase the risk of intracranial hemorrhage in cancer patients with metastasis...
News
Direct oral anticoagulants may be inappropriate for frail elderly
News
Home VTE treatment with rivaroxaban safe and effective
Key clinical point: Home treatment with rivaroxaban for patients with a low-risk first deep vein thrombosis or pulmonary embolism is safe and...